December 4th 2024
The European Commission has developed a roadmap aimed at reversing the rising trend of cancer across the European Union.
October 11th 2024
The draft joint network strategy for the EU until 2028 will be open for public consultation until Nov. 30, 2024.
October 1st 2024
Regulators, EMA and HMA, have published principles and recommendations on the use of LLMs, which are being increasingly used for daily tasks.
August 5th 2024
Germany’s Medical Research Act allows pharmaceutical companies to keep drug prices confidential.
June 5th 2024
EMA is promoting the use of RWD in decision-making and has started a public consultation to review its draft recommendations.